Directory · CH
Biotechnology in Switzerland
A register of firms and the professionals working at them in the Biotechnology sector based in Switzerland. Browse the public index, then filter or export on Kipplo.
Companies
98 on file
Genknowme
Genknowme is a Swiss-based epigenetics company dedicated to unlocking the potential of DNA methylation for both longevity-focused clinical practices and advanced biomedical research. Our mission is twofold: we support clinicians in the field of longevity medicine with science-based epigenetic testing to monitor biological aging and healthspan-related biomarkers, while also serving as a trusted partner for researchers and biotech companies seeking precision DNA methylation analysis services. By combining cutting-edge epigenomic science with robust bioinformatics, Genknowme delivers reliable, high-resolution data to support translational research, clinical development, and innovation in longevity science. Whether you're a longevity-focused clinician, a research leader, or a biotech innovator, Genknowme provides actionable insights into how lifestyle and environment shape health at the molecular level. We provide a novel blood test to support healthcare professionals while they coach their patients into making healthy lifestyle changes. Our test measures the impact of lifestyle on health at DNA level with unprecedented precision, and it is based on the science of epigenetics.
1 to 10 staff
Labgene Scientific Sa
Labgene Scientific SA is commercializing advanced high-quality products, reagents and consumables for molecular biology laboratories, facilities and platforms for 30 years. We provide integrated solutions for the life science research, diagnostic laboratories, public hospitals, forensics, government laboratories and industry. Our mission is to provide exciting new solutions that reduce laboratory time, labor and operating costs.
1 to 10 staff
Mabtree Biologics
mABTree Biologics is a biotech company based in Basel, Switzerland, focused on developing affordable, innovative monoclonal antibody therapies for hematological cancers, such as myeloproliferative neoplasms (MPNs), and autoimmune diseases. Founded in 2019, mABTree aims to make cutting-edge immunotherapies more accessible to patients worldwide. Our lead product, is a fully human antibody targeting a unique tumor marker and has shown promising preclinical results, including tumor reduction and depletion of mutant hematopoietic stem cells in MPN models. We are preparing for clinical trials and seeking partnerships and investments to accelerate development and potential regulatory approval by 2025, with a strategy for orphan drug status to expedite availability in underserved areas of oncology and hematology.
11 to 50 staff
Medxcell Sa
MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities.
11 to 50 staff
Bnovate Technologies Sa
Safe Water. Anytime. Anywhere. bNovate Technologies SA develops robust and innovative instruments to set new standards in the field of rapid microbiological monitoring for pharmaceutical and drinking water. Thanks to our proprietary and fully automated industrial flow cytometry technology you don't need to wait 3 days to get your water microbiology results back, our instruments will do it in only 20 minutes!
11 to 50 staff
Cord Blood Center Hq
We are the second biggest private cord blood bank in Europe with more than 25 years` experience, and thanks to international cooperation, our own research and continuous improvement in technology we can offer clients our considerable experience. OUR ACHIEVEMENTS We offer a method of collection and processing that makes it possible to collect and store almost the entire cell content of the blood collected. Preserving the largest possible quantity and spectrum of stem cells increases the chances of successful treatment in case of their use. To date, we have released 150 cord blood units for all types of treatment: for autologous (own blood) treatment, for siblings and also for unrelated patients. This represents the highest number compared to all other European private cord blood banks. We have active branches in 8 European countries: Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Switzerland (Headquarters) and Romania and we would like to expand into new markets. We have licensed laboratories and storage facilities in Slovakia, Romania, Austria and Czech Republic. We are the only family bank in Europe that also operates and finances a public cord blood registry – the Slovak Placental Stem Cell Registry. OUR HISTORY In 1997, we were among the first in Europe to begin working with professional preparation of cord blood transplants. We were one of the first in the field and so far we have processed and stored the cord blood, cord tissue and placenta for more than clients. In 2004, our client with a high-risk brain tumour was the first in Europe to be treated with their own cord blood with a successful outcome. Our public registry, the Slovak Placental Stem Cell Registry, is a member of the international bone marrow and cord blood donors database WMDA – the World Marrow Donor Association. The registry is connected to the EMDIS – the European Marrow Donor Information System /Network and is an associate member of International NetCord Foundation.
201 to 500 staff
Microsynth Ag
Microsynth (founded in 1989) is a leading company in Europe in the field of DNA/RNA syntheses & analyses. The main activities are divided into the following three business areas: 1. DNA/RNA SYNTHESES ›DNA/RNA oligonucleotides (unmodified, modified, various purity grades) for various R&D applications › Primers and probes (e.g. OEM kit production) for molecular diagnostics › antisense oligonucleotides as well as siRNAs for drug discovery 2. DNA/RNA ANALYSES AND SEQUENCING › DNA Sanger sequencing of all types (incl. GMP sequencing) › Next generation sequencing (de novo & re-sequencing at the genome level, RNA-Seq, metagenome and amplicon sequencing, bioinformatics, etc.) › PCR, qPCR and digital PCR › Genotyping (fragment length analysis, cell line characterization, STR marker development, GBS) › DNA/RNA isolations (all sources, including high-throughput format) 3. CONTRACT RESEARCH/OUTSOURCING › Assay establishment & validation (e.g. IVD, animal and food diagnostics) › Biological testing (e.g. lot release mRNA vaccines) › Gene editing/gene therapy (e.g. CRISPR on/off target GxP analyses, rAAV characterization) Microsynth employs >100 people and has branch offices in Germany (Microsynth Seqlab), France (Microsynth France), Austria (Microsynth Austria) and Switzerland (ecogenics). Microsynth is ISO 9001:2015, ISO 13485:2016-(oligonucleotide synthesis, kit production), ISO/IEC 17025:2017 (STS 0429)-(NGS, Sanger sequencing, fragment length analysis) and GMP certified (Sanger sequencing). We’re truly proud to be a pillar of scientific progress in pharma, biotech, and medicine. Since being founded in 1989, we’ve been incredibly passionate about the synthesis and analysis of nucleic acids - whether it is for basic research, diagnostic, or therapeutic applications. We act quickly and we’re easy to do business with, and we always show respect for the environment in everything we do.
51 to 200 staff
Polygene Ag
The core business of PolyGene is the generation and analysis of genetically modified animals for R&D purposes. Customized services include molecular biology technologies, such as vector cloning and cell biology services, such as gene targeting in embryonic stem (ES) cells or micro-injection of transgenes or ES-cells into zygotes or blastocysts. State-of-the-art technologies cover the injection of TALENs for the generation of knockout /-in animals.Founded in 2002, PolyGene is run by a team of scientists with academic and industrial backgrounds. PolyGene is a privately held SME, located in the area of Zurich, Switzerland. PolyGene actively seeks participation as a SME partner within Horizon2020 projects.
11 to 50 staff
Salveo Biotechnology Sa
Salveo Biotechnology, operational structure of Salveo Holding, is a Swiss private laboratory specialized in stem cells cryopreservation and cell culture. Created in 2011, it is also a high-tech platform made up of experts in the service of regenerative medicine. Based in Geneva, our laboratory is now helping to develop the future of medicine with its own clean room and the latest state of the art equipment. Salveo Biotechnology is also present in Italy, Spain, Romania and Ukraine.
51 to 200 staff
Biohub
Business Matchmaking Platform for Pharma Industry
1 to 10 staff
Cellntec Advanced Cell Systems
CELLnTEC is a pioneering developer of chemically defined, animal and human components-free precision media. We enable stem cell research and cell therapy development, ultimately accelerating clinical application. CELLnTEC technology helps to unravel the mechanisms of human disease, ageing and longevity. Embracing precision medicine principles, CELLnTEC facilitates a growing range of regenerative medicine developments in skin, eye, airway, and other body parts, and emerging applications such as 3D bioprinting, lab-on-a-chip, cosmeceuticals, or biohybrid systems, limits to them yet to be imagined.
51 to 200 staff
Labfinder
LabFinder establishes a centralized platform, where Laboratories and other users of laboratory equipment can easy find product and brand related suppliers in a couple of clicks and contact them in one single step, while suppliers reaches a larger audience for its products. In order to take country-specific product ranges, distribution rights and supplier contact information into account, LabFinder is available for Switzerland. Switzerland Our Platform ist available in the English, German, or French. Regarding the Users: Users of LabFinder are labs, lab technicians, purchasers and other lab related persons, who are looking for suppliers for their needs. Also suppliers can use LabFinder to get an overview of the competition in the country-specific market or to find a partner for cooperation. This functionality is free of charge and can be used either as a guest or as a registered user with an own free user account and additional benefits. Regarding the Suppliers: With LabFinder, suppliers are always on the radar of potential customers by according to their profile, identifying them as potential product and brand related suppliers and be contacted/requested in a single step. To get verified as active supplier on LabFinder, a registration for an annual fee is required. By registering, the supplier is activated and enabled for all available functions. LabFinder provides a password protected supplier account which allows to login and manage the profile and requests independently.
1 to 10 staff
Mabritec Ag
Dienstleistungen im Bereich der mikrobiologischen Diagnostik mittels Peptid Massen Fingerprinting mit MALDI-TOF MS Technologie - Technologiepartner bei F&E-Projekten
1 to 10 staff
Medical Image Analysis Laboratory
We would like to welcome you all to the page of the Medical Image Analysis Laboratory (MIAL). MIAL was born in 2011 as a research group associated with the University of Lausanne and the Centre Hospitalier Universitaire Vaudois (CHUV, Radiology department), two of the founding partners of the CIBM Center for Biomedical Imaging. We believe that the appropriate use of medical imaging requires a multidisciplinary approach. Thus, we develop advanced methods for medical image processing in close collaboration with medical doctors and industrial partners. We have several application-oriented projects in the fields of Radiology, Neurology, Neuro-surgery, Oncology, and Psychiatry.
1 to 10 staff
Navignostics Ag
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development. Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners. This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient.
11 to 50 staff
Novago Therapeutics
NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications. NovaGo’s proprietary antibodies block the function of Nogo-A, one of the most potent and well-studied vascular and nerve growth inhibitors.
1 to 10 staff
Saferworldbydesign
SaferWorldbyDesign engages a global consortium of dedicated innovators with the shared goal of advancing the science and technology necessary to protect the wellness and safety of consumers and the environment. Our part in this goal is to support the design of intelligent, effective, and safer products by providing integrated solutions to test and assess individual ingredients and formulations. Our solution-oriented platforms, solutions, and products integrate in silico and in vitro methods which support the design and testing of intelligent, safer products using new approach methods in toxicology and next-generation risk assessment. Our partners bring expertise in the best emerging research methods in toxicology, Artificial Intelligence, biology, chemistry, risk assessment, and computer science to provide a one-stop-shop for designing a safer world.
201 to 500 staff
Seneque
Seneque is a life sciences company that brings together leading cellular scientists to advance the frontiers of health and longevity. We transform breakthroughs in cellular science into consumer solutions that enhance healthspan, lifespan and vitality. Our portfolio of science-based consumer health brands use natural molecules to optimize the body’s NAD+ metabolism. Our international research platform is undertaking an extensive in-human research program that is propelling development of our proprietary NMN-C® and other synergetic molecules as NAD+ boosters to support cardiovascular, cognitive, muscular and immune health.
11 to 50 staff
Dentavis Ag - Switzerland
DENTAVIS is the exclusive distribution partner in Switzerland of the Spanish market leader for dental products BTI Biotechnology Institute. The product range, which has been successfully established worldwide for decades, extends from multiple implant lines to conventional or CADCAM-produced prosthetics for implants and specialty products such as a system for removing implants. Absolutely unique in the BTI product portfolio is the product Endoret® PRGF, which accelerates the healing of implants via growth factors. Besides implantation, it is also used for numerous other oral surgical procedures.
1 to 10 staff
Fimmcyte
First disease modifying treatment for Endometriosis
1 to 10 staff
Lucerna-Chem Ag
Lucerna-Chem is one of the leading distributors for life science products in Switzerland. Headquartered in Luzern, we provide high quality reagents and kits for diagnostics and research. Our customers are working in academics, pharma, biotech and diagnostics and basically in all fields of life sciences - cell biology, molecular biology, microbiology, biochemistry, immunology, histology, neuroscience to name a few. Though our extensive network of more than 70 innovative suppliers, we can offer a large range of products, services and custom solutions to all kinds of challenges researchers meet in their daily work.
1 to 10 staff
Ncma Consulting Gmbh
Welcome to NCMA Consulting GmbH. NCMA Consulting offers Nonclinical Management and Advice for the Biopharmaceutical and Gene Therapy Industry. NCMA Consulting provides - Strategic Advice and Interim Management for nonclinical programs - Nonclinical Study Management and Nonclinical Safety Assessment - Nonclinical Efficacy and Safety Assessments for the Gene Therapy Industry - Regulatory Interactions Dr. Jörg Herbst is the Owner and Founder of NCMA Consulting GmbH. As your experienced and goal-oriented consultant, he can rely on more than 20 years of hands-on experience in life-science organization in the pharmaceutical, biopharmaceutical industry, in which he successfully moved development candidates from research into clinical development. Dr. Herbst has the experience to understand your needs and will advice you on the best nonclinical and regulatory strategy to handle your drug candidate. His advice will be tailored exactly to your needs and provide added value for you. Visit and get in touch to discuss your project when you have a shortage of nonclinical and toxicological expertise. NCMA Consulting is ready to support your project.
1 to 10 staff
Novigenix Sa
Novigenix is a precision medicine Tech Bio offering state-of-the-art ImmunoTranscriptomic liquid biopsy solutions with unprecedented predictive capabilities for precision development of novel therapeutics. Our AI-enabled ISO-13485 certified RNA analytic platform delivers ImmunoPD biomarkers, insights into mechanism of action and resistance, and early markers for severe toxicity to accelerate clinical development. These scalable solutions are currently adopted in a number of FDA clinical trials providing actionable insights across therapeutic modalities including ADCs, radioligand therapy, cellular therapies, therapeutic vaccines, and immunotherapies. The LITOSeek™ Liquid ImmunoTranscriptOmic platform has been optimized for mapping the response of patient immune system to onset of disease and therapeutic intervention. Proprietary analytical pipelines integrate patient multi-omics data with advanced Machine Learning and artificial intelligence approaches for early detection of disease, development of novel therapeutics, and drug target discovery.
11 to 50 staff
Ormendes Sa
High Added Value Microbiotics Formulations Ormendes is a Swiss company specializing in the development and distribution of high quality microbiotics. In recent years, numerous studies have demonstrated that the microbiota is involved in many pathologies and fundamental for the proper functioning of the organism. It is now well known that an unbalanced intestinal flora can affect your health. As a result, the market of microbiotics has grown considerably. In this confusing market, consumers and healthcare professionals are struggling to see clearly among the multitude of existing products. We have therefore assembled a pool of scientific and technical skills to develop and offer innovative solutions, with proven safety of use and clinical efficacy. All of our products offered today contain a specific blend of bacteria called « SLAB51», the efficacy and safety of which have been tested and demonstrated in experimental and clinical studies. We therefore offer identifiable and traceable products from their conception to marketing.
1 to 10 staff
